|
7-F-5-MeO-MET
7-F-5-MeO-MET (5-MeO-7-F-MET, 5-Methoxy-7-fluoro-''N''-methyl-''N''-ethyltryptamine) is a tryptamine derivative which acts as a serotonin receptor agonist selective for the 5-HT2 subtypes, with a EC50#Calculation of EC50, pEC50 of 8.71 at 5-HT2A receptor, 5-HT2A, vs 8.25 at 5-HT2B receptor, 5-HT2B and 7.69 at 5-HT2C receptor, 5-HT2C. In animal tests it produced the most potent head-twitch response of a range of related fluorinated tryptamine derivatives tested, though still with slightly lower potency than psilocybin. Retrieved 2025-05-14 See also * 7-Chloro-AMT * 5-Fluoro-MET * 4-Fluoro-5-methoxy-DMT * 5-MeO-MET * Methylethyltryptamine (MET) * 5-Methoxy-7,N,N-trimethyltryptamine * O-4310 References {{Tryptamines Designer drugs N,N-Dialkyltryptamines Fluoroarenes 5-Methoxytryptamines Psychedelic tryptamines Serotonin receptor agonists ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Methylethyltryptamine
Methylethyltryptamine (MET), also known as ''N''-methyl-''N''-ethyltryptamine (''N'',''N''-MET), is a serotonergic psychedelic of the tryptamine family. It is closely related to dimethyltryptamine (DMT) and to diethyltryptamine (DET). The drug acts as an agonist of the serotonin 5-HT2 receptors and to a lesser extent as a serotonin releasing agent. It was encountered as a novel designer drug in Europe in 2014. Use and effects MET has been briefly mentioned in Alexander Shulgin's ''TiHKAL'' (''Tryptamines I Have Known and Loved'') and other publications, where he has stated it to be orally active as a psychedelic at doses of 80 to 100mg. The freebase of MET is active as a psychedelic via vaporization at a dose of 15mg per a 2011 Erowid trip report."That's okay, you're good" MET trip report - ''The Vau ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |